SynthesisDiabetes & metabolic syndrome

Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers.

Awadhesh Kumar Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.